N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update

European Journal of Pharmacology

Volumn 785, Issue , 2016, Pages 187-206

  Trépanier, Marc Olivier ^a   Hopperton, Kathryn E ^a   Orr, Sarah K ^a   Bazinet, Richard P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brain; Cytokines; Docosahexaenoic acid; Microglia; Neuroinflammation; Omega 3 polyunsaturated fatty acids

Indexed keywords

INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; N METHYL DEXTRO ASPARTIC ACID; OMEGA 3 FATTY ACID;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEPRESSION; DIABETES MELLITUS; DISEASE MODEL; DRUG EFFECT; EXCITOTOXICITY; LUPUS VULGARIS; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY; WHOLE BODY RADIATION; ANIMAL; COMPLICATION; HUMAN; INFLAMMATION; METABOLISM; NERVOUS SYSTEM DISEASES;

ANIMALS; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; NERVOUS SYSTEM DISEASES;

EID: 84934324745     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.05.045     Document Type: Article

References (137)

1. ADAPT Research Group, Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT). Alzheimer's Dement.: J. Alzheimer's Assoc. 9 (2013), 714–723.
2. Alvarez-Nolting, R., Arnal, E., Barcia, J.M., Miranda, M., Romero, F.J., Protection by DHA of early hippocampal changes in diabetes: possible role of CREB and NF-kappaB. Neurochem. Res. 37 (2012), 105–115.
3. Amminger, G.P., Schafer, M.R., Papageorgiou, K., Klier, C.M., Cotton, S.M., Harrigan, S.M., Mackinnon, A., McGorry, P.D., Berger, G.E., Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch. Gen. Psychiatry 67 (2010), 146–154.
4. Ballesteros-Zebadua, P., Chavarria, A., Celis, M.A., Paz, C., Franco-Perez, J., Radiation-induced neuroinflammation and radiation somnolence syndrome. CNS Neurol. Disord. Drug Targets 11 (2012), 937–949.
5. Banks, W.A., The blood-brain barrier in neuroimmunology: Tales of separation and assimilation. Brain, behavior, and immunity 44 (2015), 1–8.
6. Barden, A., Mas, E., Croft, K.D., Phillips, M., Mori, T.A., Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation. J Lipid Res. 55 (2014), 2401–2407.
7. Baron, R., Neuropathic pain: a clinical perspective. Handb. Exp. Pharmacol., 2009, 3–30.
8. Bazan, N.G., Eady, T.N., Khoutorova, L., Atkins, K.D., Hong, S., Lu, Y., Zhang, C., Jun, B., Obenaus, A., Fredman, G., Zhu, M., Winkler, J.W., Petasis, N.A., Serhan, C.N., Belayev, L., Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke. Exp. Neurol. 236 (2012), 122–130.
9. Bazinet, R.P., Laye, S., Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci., 2014 epub ahead of print.
10. Belayev, L., Khoutorova, L., Atkins, K.D., Bazan, N.G., Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke J. Cereb. Circ. 40 (2009), 3121–3126.
11. Belayev, L., Khoutorova, L., Atkins, K.D., Eady, T.N., Hong, S., Lu, Y., Obenaus, A., Bazan, N.G., Docosahexaenoic acid therapy of experimental ischemic stroke. Transl. Stroke Res. 2 (2011), 33–41.
12. Black, K.L., Hsu, S., Radin, N.S., Hoff, J.T., Effect of intravenous eicosapentaenoic acid on cerebral blood flow, edema and brain prostaglandins in ischemic gerbils. Prostaglandins 28 (1984), 545–556.
13. Bousquet, M., Calon, F., Cicchetti, F., Impact of omega-3 fatty acids in Parkinson's disease. Ageing Res. Rev. 10 (2011), 453–463.
14. Bousquet, M., Gue, K., Emond, V., Julien, P., Kang, J.X., Cicchetti, F., Calon, F., Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease. J. Lipid Res. 52 (2011), 263–271.
15. Butovsky, O., Jedrychowski, M.P., Moore, C.S., Cialic, R., Lanser, A.J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P.M., Doykan, C.E., Fanek, Z., Liu, L., Chen, Z., Rothstein, J.D., Ransohoff, R.M., Gygi, S.P., Antel, J.P., Weiner, H.L., Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat. Neurosci. 17 (2014), 131–143.
16. Cai, D., Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends Endocrinol Metab.: TEM 24 (2013), 40–47.
17. Calder, P.C., n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83 (2006), 1505S–1519S.
18. Carson, M.J., Doose, J.M., Melchior, B., Schmid, C.D., Ploix, C.C., CNS immune privilege: hiding in plain sight. Immunol. Rev. 213 (2006), 48–65.
19. Carson, M.J., Thrash, J.C., Walter, B., The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin. Neurosci. Res. 6 (2006), 237–245.
20. Chang, C.Y., Kuan, Y.H., Li, J.R., Chen, W.Y., Ou, Y.C., Pan, H.C., Liao, S.L., Raung, S.L., Chang, C.J., Chen, C.J., Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. J. Nutr. Biochem. 24 (2013), 2127–2137.
21. Cherry, J.D., Olschowka, J.A., O'Banion, M.K., Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J. Neuroinflamm., 11, 2014, 98.
22. Chhor, V., Le Charpentier, T., Lebon, S., Ore, M.V., Celador, I.L., Josserand, J., Degos, V., Jacotot, E., Hagberg, H., Savman, K., Mallard, C., Gressens, P., Fleiss, B., Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav. Immun. 32 (2013), 70–85.
23. Choi, S.H., Aid, S., Bosetti, F., The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends in pharmacological sciences 30 (2009), 174–181.
24. Cohen, S.P., Mao, J., Neuropathic pain: mechanisms and their clinical implications. BMJ Clinical Research Ed., 348, 2014, 7656.
25. Colas, R.A., Shinohara, M., Dalli, J., Chiang, N., Serhan, C.N., Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am. J. Physiol. Cell Physiol. 307 (2014), C39–C54.
26. Crupi, R., Cambiaghi, M., Deckelbaum, R., Hansen, I., Mindes, J., Spina, E., Battaglia, F., n-3 fatty acids prevent impairment of neurogenesis and synaptic plasticity in B-cell activating factor (BAFF) transgenic mice. Prev. Med., 54, 2012 Suppl, S103-108.
27. Crupi, R., Cambiaghi, M., Spatz, L., Hen, R., Thorn, M., Friedman, E., Vita, G., Battaglia, F., Reduced adult neurogenesis and altered emotional behaviors in autoimmune-prone B-cell activating factor transgenic mice. Biol. Psychiatry 67 (2010), 558–566.
28. Dawczynski, C., Massey, K.A., Ness, C., Kiehntopf, M., Stepanow, S., Platzer, M., Grun, M., Nicolaou, A., Jahreis, G., Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: effects on circulating eicosanoids and cardiovascular risk factors. Clin. Nutr. 32 (2013), 686–696.
29. Delpech, J.C., Madore, C., Joffre, C., Aubert, A., Kang, J.X., Nadjar, A., Laye, S., Transgenic increase in n-3/n-6 fatty acid ratio protects against cognitive deficits induced by an immune challenge through decrease of neuroinflammation. Neuropsychopharmacol.: Offic. Publ. Am. Coll. Neuropsychopharmacol., 2014.
30. DeMar, J.C. Jr., Lee, H.J., Ma, K., Chang, L., Bell, J.M., Rapoport, S.I., Bazinet, R.P., Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochim. Biophys. Acta 1761 (2006), 1050–1059.
31. Donnelly, D.J., Popovich, P.G., Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol. 209 (2008), 378–388.
32. Eady, T.N., Belayev, L., Khoutorova, L., Atkins, K.D., Zhang, C., Bazan, N.G., Docosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats. PLoS One, 7, 2012, e46151.
33. Eady, T.N., Khoutorova, L., Atkins, K.D., Bazan, N.G., Belayev, L., Docosahexaenoic acid complexed to human albumin in experimental stroke: neuroprotective efficacy with a wide therapeutic window. Exp. Transl. Stroke Med., 4, 2012, 19.
34. Eady, T.N., Khoutorova, L., Obenaus, A., Mohd-Yusof, A., Bazan, N.G., Belayev, L., Docosahexaenoic acid complexed to albumin provides neuroprotection after experimental stroke in aged rats. Neurobiol. Dis. 62 (2014), 1–7.
35. Figueroa, J.D., Cordero, K., Baldeosingh, K., Torrado, A.I., Walker, R.L., Miranda, J.D., Leon, M.D., Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats. J. Neurotrauma 29 (2012), 551–566.
36. Freund-Levi, Y., Eriksdotter-Jonhagen, M., Cederholm, T., Basun, H., Faxen-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.O., Palmblad, J., Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch. Neurol. 63 (2006), 1402–1408.
37. Glass, C.K., Saijo, K., Winner, B., Marchetto, M.C., Gage, F.H., Mechanisms underlying inflammation in neurodegeneration. Cell 140 (2010), 918–934.
38. Green, J.T., Orr, S.K., Bazinet, R.P., The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids. J. Lipid Res. 49 (2008), 939–944.
39. Hall, J.C., Priestley, J.V., Perry, V.H., Michael-Titus, A.T., Docosahexaenoic acid, but not eicosapentaenoic acid, reduces the early inflammatory response following compression spinal cord injury in the rat. J. Neurochem. 121 (2012), 738–750.
40. Hanisch, U.K., Kettenmann, H., Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10 (2007), 1387–1394.
41. Harrison, J.L., Rowe, R.K., Ellis, T.W., Yee, N.S., O'Hara, B.F., David Adelson, P., Lifshitz, J., Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse. Brain Bbehav. Immun., 2015.
42. Hashimoto, M., Maekawa, M., Katakura, M., Hamazaki, K., Matsuoka, Y., Possibility of polyunsaturated fatty acids for the prevention and treatment of neuropsychiatric illnesses. J. Pharmacol. Sci. 124 (2014), 294–300.
43. Heneka, M.T., Carson, M.J., Khoury, J.E., Landreth, G.E., Brosseron, F., Feinstein, D.L., Jacobs, A.H., Wyss-Coray, T., Vitorica, J., Ransohoff, R.M., Herrup, K., Frautschy, S.A., Finsen, B., Brown, G.C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., Petzold, G.C., Town, T., Morgan, D., Shinohara, M.L., Perry, V.H., Holmes, C., Bazan, N.G., Brooks, D.J., Hunot, S., Joseph, B., Deigendesch, N., Garaschuk, O., Boddeke, E., Dinarello, C.A., Breitner, J.C., Cole, G.M., Golenbock, D.T., Kummer, M.P., Neuroinflammation in Alzheimer's disease. Lancet Neurol. 14 (2015), 388–405.
44. Hjorth, E., Freund-Levi, Y., Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid. Curr. Opin. Clin. Nutr. Metab. Care 15 (2012), 134–143.
45. Hjorth, E., Zhu, M., Toro, V.C., Vedin, I., Palmblad, J., Cederholm, T., Freund-Levi, Y., Faxen-Irving, G., Wahlund, L.O., Basun, H., Eriksdotter, M., Schultzberg, M., Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-beta42 by human microglia and decrease inflammatory markers. J. Alzheimer's Dis.: JAD 35 (2013), 697–713.
46. Hong, S., Gronert, K., Devchand, P.R., Moussignac, R.L., Serhan, C.N., Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 278 (2003), 14677–14687.
47. Hooijmans, C.R., Pasker-de Jong, P.C., de Vries, R.B., Ritskes-Hoitinga, M., The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis. J. Alzheimer's Dis.: JAD, 28, 2012, 191–209.
48. Huang, W.L., King, V.R., Curran, O.E., Dyall, S.C., Ward, R.E., Lal, N., Priestley, J.V., Michael-Titus, A.T., A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 130 (2007), 3004–3019.
49. Igarashi, M., DeMar, J.C. Jr., Ma, K., Chang, L., Bell, J.M., Rapoport, S.I., Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J. Lipid Res. 48 (2007), 1150–1158.
50. Imai, F., Suzuki, H., Oda, J., Ninomiya, T., Ono, K., Sano, H., Sawada, M., Neuroprotective effect of exogenous microglia in global brain ischemia. J. Cereb. Blood Flow and Metab.: Offic. J. Int. Soc. Cereb. Blood Flow Metab. 27 (2007), 488–500.
51. Jaturapatporn, D., Isaac, M.G., McCleery, J., Tabet, N., Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease. Cochrane Database Syst. Rev., 2, 2012, CD006378.
52. Ji, A., Diao, H., Wang, X., Yang, R., Zhang, J., Luo, W., Cao, R., Cao, Z., Wang, F., Cai, T., n-3 polyunsaturated fatty acids inhibit lipopolysaccharide-induced microglial activation and dopaminergic injury in rats. Neurotoxicology 33 (2012), 780–788.
53. Jia, D., Heng, L.J., Yang, R.H., Gao, G.D., Fish oil improves learning impairments of diabetic rats by blocking PI3K/AKT/nuclear factor-kappaB-mediated inflammatory pathways. Neuroscience 258 (2014), 228–237.
54. Kavanagh, T., Lonergan, P.E., Lynch, M.A., Eicosapentaenoic acid and gamma-linolenic acid increase hippocampal concentrations of IL-4 and IL-10 and abrogate lipopolysaccharide-induced inhibition of long-term potentiation. Prostaglandins Leukot. Essent. Fatty Acids 70 (2004), 391–397.
55. Keleshian, V.L., Kellom, M., Kim, H.W., Taha, A.Y., Cheon, Y., Igarashi, M., Rapoport, S.I., Rao, J.S., Neuropathological responses to chronic NMDA in rats are worsened by dietary n-3 PUFA deprivation but are not ameliorated by fish oil supplementation. PLoS One, 9, 2014, e95318.
56. Kelly, J.P., Wrynn, A.S., Leonard, B.E., The olfactory bulbectomized rat as a model of depression: an update. Pharmacol. Ther. 74 (1997), 299–316.
57. Kelly, L., Grehan, B., Chiesa, A.D., O'Mara, S.M., Downer, E., Sahyoun, G., Massey, K.A., Nicolaou, A., Lynch, M.A., The polyunsaturated fatty acids, EPA and DPA exert a protective effect in the hippocampus of the aged rat. Neurobiol. Aging 32:2318 (2011), e2311–2315.
58. King, V.R., Huang, W.L., Dyall, S.C., Curran, O.E., Priestley, J.V., Michael-Titus, A.T., Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J. Neurosci. 26 (2006), 4672–4680.
59. Kyrkanides, S., Olschowka, J.A., Williams, J.P., Hansen, J.T., O'Banion, M.K., TNF alpha and IL-1beta mediate intercellular adhesion molecule-1 induction via microglia-astrocyte interaction in CNS radiation injury. J. Neuroimmunol. 95 (1999), 95–106.
60. Labrousse, V.F., Nadjar, A., Joffre, C., Costes, L., Aubert, A., Gregoire, S., Bretillon, L., Laye, S., Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice. PLoS One, 7, 2012, e36861.
61. Lalancette-Hebert, M., Gowing, G., Simard, A., Weng, Y.C., Kriz, J., Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci.: Offic. J. Soc. Neurosci. 27 (2007), 2596–2605.
62. Lalancette-Hebert, M., Julien, C., Cordeau, P., Bohacek, I., Weng, Y.C., Calon, F., Kriz, J., Accumulation of dietary docosahexaenoic acid in the brain attenuates acute immune response and development of postischemic neuronal damage. Stroke J. Cereb. Circ. 42 (2011), 2903–2909.
63. Lang-Lazdunski, L., Blondeau, N., Jarretou, G., Lazdunski, M., Heurteaux, C., Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. J. Vasc. Surg. 38 (2003), 564–575.
64. Lebbadi, M., Julien, C., Phivilay, A., Tremblay, C., Emond, V., Kang, J.X., Calon, F., Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease. J. Alzheimer's Dis.: JAD, 27, 2011, 853–869.
65. Leonard, B.E., Song, C., Changes in the immune system in rodent models of depression. Int. J. Neuropsychopharmacol./Offic. Sci. J. Coll. Int. Neuropsychopharmacol. (CINP) 5 (2002), 345–356.
66. Lim, S.N., Gladman, S.J., Dyall, S.C., Patel, U., Virani, N., Kang, J.X., Priestley, J.V., Michael-Titus, A.T., Transgenic mice with high endogenous omega-3 fatty acids are protected from spinal cord injury. Neurobiol. Dis. 51 (2013), 104–112.
67. Lim, S.N., Huang, W., Hall, J.C., Michael-Titus, A.T., Priestley, J.V., Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid. Exp. Neurol. 239 (2013), 13–27.
68. Lim, S.N., Huang, W., Hall, J.C., Ward, R.E., Priestley, J.V., Michael-Titus, A.T., The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats. Prostaglandins Leukot. Essent. Fatty Acids 83 (2010), 193–201.
69. Liu, J.J., Green, P., John Mann, J., Rapoport, S.I., Sublette, M.E., Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease. Brain Res., 2014.
70. Loane, D.J., Byrnes, K.R., Role of microglia in neurotrauma. Neurother.: J. Am. Soc. Exp. NeuroTher. 7 (2010), 366–377.
71. Lonergan, P.E., Martin, D.S., Horrobin, D.F., Lynch, M.A., Neuroprotective actions of eicosapentaenoic acid on lipopolysaccharide-induced dysfunction in rat hippocampus. J. Neurochem. 91 (2004), 20–29.
72. Luchtman, D.W., Meng, Q., Song, C., Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease. Behav. Brain Res. 226 (2012), 386–396.
73. Lukiw, W.J., Cui, J.G., Marcheselli, V.L., Bodker, M., Botkjaer, A., Gotlinger, K., Serhan, C.N., Bazan, N.G., A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Investig. 115 (2005), 2774–2783.
74. Luo, C., Ren, H., Wan, J.B., Yao, X., Zhang, X., He, C., So, K.F., Kang, J.X., Pei, Z., Su, H., Enriched endogenous omega-3 fatty acids in mice protect against global ischemia injury. J. Lipid Res., 2014.
75. Lynch, A.M., Loane, D.J., Minogue, A.M., Clarke, R.M., Kilroy, D., Nally, R.E., Roche, O.J., O'Connell, F., Lynch, M.A., Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus. Neurobiol. Aging 28 (2007), 845–855.
76. Lynch, A.M., Moore, M., Craig, S., Lonergan, P.E., Martin, D.S., Lynch, M.A., Analysis of interleukin-1 beta-induced cell signaling activation in rat hippocampus following exposure to gamma irradiation. Protective effect of eicosapentaenoic acid. J. Biol. Chem. 278 (2003), 51075–51084.
77. Maher, F.O., Martin, D.S., Lynch, M.A., Increased IL-1beta in cortex of aged rats is accompanied by downregulation of ERK and PI-3 kinase. Neurobiol. Aging 25 (2004), 795–806.
78. Marcheselli, V.L., Hong, S., Lukiw, W.J., Tian, X.H., Gronert, K., Musto, A., Hardy, M., Gimenez, J.M., Chiang, N., Serhan, C.N., Bazan, N.G., Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278 (2003), 43807–43817.
79. Martin, D.S., Lonergan, P.E., Boland, B., Fogarty, M.P., Brady, M., Horrobin, D.F., Campbell, V.A., Lynch, M.A., Apoptotic changes in the aged brain are triggered by interleukin-1beta-induced activation of p38 and reversed by treatment with eicosapentaenoic acid. J. Biol. Chem. 277 (2002), 34239–34246.
80. Mashour, G.A., Woodrum, D.T., Avidan, M.S., Neurological complications of surgery and anaesthesia. Br. J. Anaesthesia, 2014.
81. Matsumoto, H., Kumon, Y., Watanabe, H., Ohnishi, T., Shudou, M., Ii, C., Takahashi, H., Imai, Y., Tanaka, J., Antibodies to CD11b, CD68, and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions. J. Neurosci. Res. 85 (2007), 994–1009.
82. Mayer, C.L., Huber, B.R., Peskind, E., Traumatic brain injury, neuroinflammation, and post-traumatic headaches. Headache 53 (2013), 1523–1530.
83. Meng, Q., Luchtman, D.W., El Bahh, B., Zidichouski, J.A., Yang, J., Song, C., Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices. Eur. J. Pharmacol. 649 (2010), 127–134.
84. Michaud, J.P., Halle, M., Lampron, A., Theriault, P., Prefontaine, P., Filali, M., Tribout-Jover, P., Lanteigne, A.M., Jodoin, R., Cluff, C., Brichard, V., Palmantier, R., Pilorget, A., Larocque, D., Rivest, S., Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology. Proc. Natl. Acad. Sci. USA 110 (2013), 1941–1946.
85. Mills, J.D., Hadley, K., Bailes, J.E., Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury. Neurosurgery 68 (2011), 474–481 discussion 481.
86. Mingam, R., Moranis, A., Bluthe, R.M., De Smedt-Peyrusse, V., Kelley, K.W., Guesnet, P., Lavialle, M., Dantzer, R., Laye, S., Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice. Eur. J. Neurosci. 28 (2008), 1877–1886.
87. Minogue, A.M., Lynch, A.M., Loane, D.J., Herron, C.E., Lynch, M.A., Modulation of amyloid-beta-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid. J. Neurochem. 103 (2007), 914–926.
88. Mischoulon, D., Nierenberg, A.A., Schettler, P.J., Kinkead, B.L., Fehling, K., Martinson, M.A., Hyman Rapaport, M., A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression. J. Clin. Psychiatry 76 (2015), 54–61.
89. Moranis, A., Delpech, J.C., De Smedt-Peyrusse, V., Aubert, A., Guesnet, P., Lavialle, M., Joffre, C., Laye, S., Long term adequate n-3 polyunsaturated fatty acid diet protects from depressive-like behavior but not from working memory disruption and brain cytokine expression in aged mice. Brain Behav. Immun. 26 (2012), 721–731.
90. Mosher, K.I., Wyss-Coray, T., Microglial dysfunction in brain aging and Alzheimer's disease. Biochem. Pharmacol. 88 (2014), 594–604.
91. Muntane, G., Janue, A., Fernandez, N., Odena, M.A., Oliveira, E., Boluda, S., Portero-Otin, M., Naudi, A., Boada, J., Pamplona, R., Ferrer, I., Modification of brain lipids but not phenotype in alpha-synucleinopathy transgenic mice by long-term dietary n-3 fatty acids. Neurochem. Int. 56 (2010), 318–328.
92. Myint, A.M., Steinbusch, H.W., Goeghegan, L., Luchtman, D., Kim, Y.K., Leonard, B.E., Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression. Neuroimmunomodulation 14 (2007), 65–71.
93. Najjar, S., Pearlman, D.M., Alper, K., Najjar, A., Devinsky, O., Neuroinflammation and psychiatric illness. J. Neuroinflamm., 10, 2013, 43.
94. Okabe, N., Nakamura, T., Toyoshima, T., Miyamoto, O., Lu, F., Itano, T., Eicosapentaenoic acid prevents memory impairment after ischemia by inhibiting inflammatory response and oxidative damage. J. Stroke Cerebrovasc. Dis.: Offic. J. Natl. Stroke Assoc. 20 (2011), 188–195.
95. Orr, S.K., Palumbo, S., Bosetti, F., Mount, H.T., Kang, J.X., Greenwood, C.E., Ma, D.W., Serhan, C.N., Bazinet, R.P., Unesterified docosahexaenoic acid is protective in neuroinflammation. J. Neurochem. 127 (2013), 378–393.
96. Orr, S.K., Tong, J.Y., Kang, J.X., Ma, D.W., Bazinet, R.P., The fat-1 mouse has brain docosahexaenoic acid levels achievable through fish oil feeding. Neurochem. Res. 35 (2010), 811–819.
97. Orr, S.K., Trepanier, M.O., Bazinet, R.P., n-3 Polyunsaturated fatty acids in animal models with neuroinflammation. Prostaglandins Leukot. Essent. Fatty Acids 88 (2013), 97–103.
98. Pan, H.C., Kao, T.K., Ou, Y.C., Yang, D.Y., Yen, Y.J., Wang, C.C., Chuang, Y.H., Liao, S.L., Raung, S.L., Wu, C.W., Chiang, A.N., Chen, C.J., Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J. Nutr. biochem. 20 (2009), 715–725.
99. Parrott, M.D., Winocur, G., Bazinet, R.P., Ma, D.W., Greenwood, C.E., Whole-food diet worsened cognitive dysfunction in an Alzheimer's disease mouse model. Neurobiol. Aging 36 (2015), 90–99.
100. Paterniti, I., Impellizzeri, D., Di Paola, R., Esposito, E., Gladman, S., Yip, P., Priestley, J.V., Michael-Titus, A.T., Cuzzocrea, S., Docosahexaenoic acid attenuates the early inflammatory response following spinal cord injury in mice: in-vivo and in-vitro studies. J. Neuroinflamm., 11, 2014, 6.
101. Prinz, M., Priller, J., Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat. Rev. Neurosci. 15 (2014), 300–312.
102. Pu, H., Guo, Y., Zhang, W., Huang, L., Wang, G., Liou, A.K., Zhang, J., Zhang, P., Leak, R.K., Wang, Y., Chen, J., Gao, Y., Omega-3 polyunsaturated fatty acid supplementation improves neurologic recovery and attenuates white matter injury after experimental traumatic brain injury. J. Cereb. Blood Flow and Metab.: Offic. J. Int. Soc. Cereb. Blood Flow Metab. 33 (2013), 1474–1484.
103. Rao, J.S., Ertley, R.N., Lee, H.J., DeMar, J.C. Jr., Arnold, J.T., Rapoport, S.I., Bazinet, R.P., n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol. Psychiatry 12 (2007), 36–46.
104. Rees, K., Stowe, R., Patel, S., Ives, N., Breen, K., Clarke, C.E., Ben-Shlomo, Y., Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies. Cochrane Database Syst. Rev., 2011, CD008454.
105. Saijo, K., Winner, B., Carson, C.T., Collier, J.G., Boyer, L., Rosenfeld, M.G., Gage, F.H., Glass, C.K., A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137 (2009), 47–59.
106. Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., Soininen, H., Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype. Eur. J. Neurosci. 34 (2011), 3–11.
107. Schomberg, D., Olson, J.K., Immune responses of microglia in the spinal cord: contribution to pain states. Exp. Neurol. 234 (2012), 262–270.
108. Schwartz, M., Baruch, K., The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J. 33 (2014), 7–22.
109. Serhan, C.N., Pro-resolving lipid mediators are leads for resolution physiology. Nature 510 (2014), 92–101.
110. Serhan, C.N., Chiang, N., Resolution phase lipid mediators of inflammation: agonists of resolution. Curr. Opin. Pharmacol. 13 (2013), 632–640.
111. Serhan, C.N., Chiang, N., Van Dyke, T.E., Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8 (2008), 349–361.
112. Song, C., Horrobin, D., Omega-3 fatty acid ethyl-eicosapentaenoate, but not soybean oil, attenuates memory impairment induced by central IL-1beta administration. J. Lipid Res. 45 (2004), 1112–1121.
113. Song, C., Manku, M.S., Horrobin, D.F., Long-chain polyunsaturated fatty acids modulate interleukin-1beta-induced changes in behavior, monoaminergic neurotransmitters, and brain inflammation in rats. J. Nutr. 138 (2008), 954–963.
114. Song, C., Zhang, X.Y., Manku, M., Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment. J. Neurosci. 29 (2009), 14–22.
115. Suridjan, I., Pollock, B.G., Verhoeff, N.P., Voineskos, A.N., Chow, T., Rusjan, P.M., Lobaugh, N.J., Houle, S., Mulsant, B.H., Mizrahi, R., In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [F]-FEPPA. Mol. Psychiatry, 2015.
116. Taepavarapruk, P., Song, C., Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1beta administrations: effects of omega-3 fatty acid EPA treatment. J. Neurochem. 112 (2010), 1054–1064.
117. Tansey, M.G., Goldberg, M.S., Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol. Dis. 37 (2010), 510–518.
118. Terrando, N., Gomez-Galan, M., Yang, T., Carlstrom, M., Gustavsson, D., Harding, R.E., Lindskog, M., Eriksson, L.I., Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline. FASEB J. 27 (2013), 3564–3571.
119. Thal, L.J., Ferris, S.H., Kirby, L., Block, G.A., Lines, C.R., Yuen, E., Assaid, C., Nessly, M.L., Norman, B.A., Baranak, C.C., Reines, S.A., A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacol.: Offic. Publ. Am. Coll. Neuropsychopharmacol. 30 (2005), 1204–1215.
120. Torkildsen, O., Wergeland, S., Bakke, S., Beiske, A.G., Bjerve, K.S., Hovdal, H., Midgard, R., Lilleas, F., Pedersen, T., Bjornara, B., Dalene, F., Kleveland, G., Schepel, J., Olsen, I.C., Myhr, K.M., omega-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch. Neurol. 69 (2012), 1044–1051.
121. Trepanier, M.O., Taha, A.Y., Mantha, R.L., Ciobanu, F.A., Zeng, Q.H., Tchkhartichvili, G.M., Domenichiello, A.F., Bazinet, R.P., Burnham, W.M., Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses. Epilepsy Res. 99 (2012), 225–232.
122. Wang, D., Couture, R., Hong, Y., Activated microglia in the spinal cord underlies diabetic neuropathic pain. Eur. J. Pharmacol. 728 (2014), 59–66.
123. Wang, J., Tan, L., Wang, H.F., Tan, C.C., Meng, X.F., Wang, C., Tang, S.W., Yu, J.T., Anti-inflammatory drugs and risk of alzheimer's disease: an updated systematic review and meta-analysis. J. Alzheimer's Dis.: JAD, 2014.
124. Wang, X., Zhu, M., Hjorth, E., Cortes-Toro, V., Eyjolfsdottir, H., Graff, C., Nennesmo, I., Palmblad, J., Eriksdotter, M., Sambamurti, K., Fitzgerald, J.M., Serhan, C.N., Granholm, A.C., Schultzberg, M., Resolution of inflammation is altered in Alzheimer's disease. Alzheimer's Dement.: J. Alzheimer's Assoc., 2014.
125. Wang, Y., Armando, A.M., Quehenberger, O., Yan, C., Dennis, E.A., Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples. J. Chromatogr. A 1359 (2014), 60–69.
126. Wang, Y., Jin, S., Sonobe, Y., Cheng, Y., Horiuchi, H., Parajuli, B., Kawanokuchi, J., Mizuno, T., Takeuchi, H., Suzumura, A., Interleukin-1beta induces blood-brain barrier disruption by downregulating sonic hedgehog in astrocytes. PloS One, 9, 2014, e110024.
127. Woodcock, T., Morganti-Kossmann, M.C., The role of markers of inflammation in traumatic brain injury. Front. Neurol., 4, 2013, 18.
128. Xu, Z.Z., Berta, T., Ji, R.R., Resolvin E1 inhibits neuropathic pain and spinal cord microglial activation following peripheral nerve injury. J. Neuroimmune Pharmacol.: Offic. J. Soc. NeuroImmune Pharmacol. 8 (2013), 37–41.
129. Xu, Z.Z., Liu, X.J., Berta, T., Park, C.K., Lu, N., Serhan, C.N., Ji, R.R., Neuroprotectin/protectin D1 protects against neuropathic pain in mice after nerve trauma. Ann. Neurol. 74 (2013), 490–495.
130. Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A.M., Cialic, R., Wu, P.M., Doykan, C.E., Lin, J., Cotleur, A.C., Kidd, G., Zorlu, M.M., Sun, N., Hu, W., Liu, L., Lee, J.C., Taylor, S.E., Uehlein, L., Dixon, D., Gu, J., Floruta, C.M., Zhu, M., Charo, I.F., Weiner, H.L., Ransohoff, R.M., Differential roles of microglia and monocytes in the inflamed central nervous system. J. Exp. Med. 211 (2014), 1533–1549.
131. Yang, D.Y., Pan, H.C., Yen, Y.J., Wang, C.C., Chuang, Y.H., Chen, S.Y., Lin, S.Y., Liao, S.L., Raung, S.L., Wu, C.W., Chou, M.C., Chiang, A.N., Chen, C.J., Detrimental effects of post-treatment with fatty acids on brain injury in ischemic rats. Neurotoxicology 28 (2007), 1220–1229.
132. Yates, C.M., Calder, P.C., Ed Rainger, G., Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol. Ther., 141, 2014, 272–282.
133. Yip, P.K., Pizzasegola, C., Gladman, S., Biggio, M.L., Marino, M., Jayasinghe, M., Ullah, F., Dyall, S.C., Malaspina, A., Bendotti, C., Michael-Titus, A., The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis. PLoS One, 8, 2013, e61626.
134. Zendedel, A., Habib, P., Dang, J., Lammerding, L., Hoffmann, S., Beyer, C., Slowik, A., Omega-3 polyunsaturated fatty acids ameliorate neuroinflammation and mitigate ischemic stroke damage through interactions with astrocytes and microglia. J. Neuroimmunol. 278 (2015), 200–211.
135. Zhang, W., Hu, X., Yang, W., Gao, Y., Chen, J., Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions. Stroke J. Cereb. Circ. 41 (2010), 2341–2347.
136. Tian, Y., Zhang, Y., Zhang, R., Qiao, S., Fan, J., Resolvin D2 recovers neural injury by suppressing inflammatory mediators expression in lipopolysaccharide-induced Parkinson's disease rat model. Biochemical and biophysical research communications 460 (2015), 799–805.
137. Zhao, Y., Calon, F., Julien, C., Winkler, J.W., Petasis, N.A., Lukiw, W.J., Bazan, N.G., Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARgamma-mediated mechanisms in Alzheimer's disease models. PloS One, 6, 2011, e15816.